Northern Trust’s X4 Pharmaceuticals XFOR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-41,794
Closed -$296K 4504
2025
Q1
$296K Sell
41,794
-3,457
-8% -$24.5K ﹤0.01% 3796
2024
Q4
$996K Buy
45,251
+1,264
+3% +$27.8K ﹤0.01% 3395
2024
Q3
$883K Buy
43,987
+8,787
+25% +$176K ﹤0.01% 3402
2024
Q2
$612K Buy
35,200
+50
+0.1% +$870 ﹤0.01% 3431
2024
Q1
$1.47M Sell
35,150
-283
-0.8% -$11.8K ﹤0.01% 3131
2023
Q4
$891K Sell
35,433
-157
-0.4% -$3.95K ﹤0.01% 3351
2023
Q3
$1.16M Buy
35,590
+527
+2% +$17.2K ﹤0.01% 3238
2023
Q2
$2.04M Buy
35,063
+27,581
+369% +$1.61M ﹤0.01% 2995
2023
Q1
$195K Buy
7,482
+2,592
+53% +$67.7K ﹤0.01% 3866
2022
Q4
$146K Buy
4,890
+2,050
+72% +$61.1K ﹤0.01% 3985
2022
Q3
$146K Buy
2,840
+981
+53% +$50.4K ﹤0.01% 3993
2022
Q2
$54K Buy
1,859
+11
+0.6% +$320 ﹤0.01% 4383
2022
Q1
$97K Sell
1,848
-402
-18% -$21.1K ﹤0.01% 4348
2021
Q4
$155K Sell
2,250
-12
-0.5% -$827 ﹤0.01% 4289
2021
Q3
$359K Sell
2,262
-23
-1% -$3.65K ﹤0.01% 3895
2021
Q2
$446K Sell
2,285
-3,728
-62% -$728K ﹤0.01% 3756
2021
Q1
$1.55M Sell
6,013
-920
-13% -$238K ﹤0.01% 3379
2020
Q4
$1.34M Sell
6,933
-768
-10% -$148K ﹤0.01% 3392
2020
Q3
$1.57M Sell
7,701
-331
-4% -$67.3K ﹤0.01% 3173
2020
Q2
$2.25M Buy
8,032
+1,913
+31% +$535K ﹤0.01% 2980
2020
Q1
$1.84M Buy
6,119
+1,470
+32% +$441K ﹤0.01% 2902
2019
Q4
$1.49M Buy
4,649
+843
+22% +$271K ﹤0.01% 3258
2019
Q3
$1.45M Buy
3,806
+2,937
+338% +$1.12M ﹤0.01% 3261
2019
Q2
$392K Buy
+869
New +$392K ﹤0.01% 3622
2019
Q1
Sell
-303
Closed -$127K 4264
2018
Q4
$127K Buy
303
+19
+7% +$7.96K ﹤0.01% 3875
2018
Q3
$83K Buy
284
+5
+2% +$1.46K ﹤0.01% 4062
2018
Q2
$182K Buy
279
+101
+57% +$65.9K ﹤0.01% 3887
2018
Q1
$735K Buy
+178
New +$735K ﹤0.01% 3467